S-1 in the treatment of pancreatic cancer

doi:10.3748/wjg.v20.i41.15110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 41

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8801)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-7) series.

Item

Count

PDF

638

WORD

231

HTML

5144

Tables (1-7)

165

Sum=6178

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1493

Download

1130

Sum=2623

Nov 7, 2014 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 7, 2014; 20(41): 15110-15118
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15110

Table 4 Phase II studies of S-1 for gemcitabine refractory pancreatic cancer

Ref.	n	ORR	PFS (mo)	MST (mo)
Morizane et al[34]	40	15.0%	2.0	4.5
Sudo et al[35]	21	9.5%	4.1	6.3

PFS: Progression-free survival; MST: Median survival time; ORR: Objective response rate.

Citation: Sudo K, Nakamura K, Yamaguchi T. S-1 in the treatment of pancreatic cancer. World J Gastroenterol 2014; 20(41): 15110-15118
URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15110.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i41.15110